With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also hoping to win over national coverage from CMS.
Mobile and digital health technologies have become so popular that they are almost ubiquitous, but it is easy to forget that these are still relatively new fields in terms of clinical effectiveness, a new literature review shows.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.